Aptorum Group

Curated by Signal

Developer of small molecular therapeutics for multiple disorders

Life Sciences Technologyaptorumgroup.com

Overview

Developer of small molecular therapeutics for multiple disorders. The company's drug candidates include SACT-1 for neuroblastoma, ALS-4 for staphylococcus infection, ALS-1 for influenza, ALS-2 for bacterial infection, NLS-1 for endometriosis, and others.

Key facts

Founded: 2017
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Cyclic Diagnostics
Developer of point-of-care test solutions for fertility care
Life Sciences TechnologyCambridge, United Kingdom
Blue Tractor Software
Provider of DNA sequence analysis software
Life Sciences TechnologyLlanfairfechan, United Kingdom
MultiplAI Health
Developer of an AI-enabled in vitro diagnostic system for the detection of cancer
Life Sciences TechnologyLondon, United Kingdom

About Aptorum Group

What does Aptorum Group do?

Developer of small molecular therapeutics for multiple disorders.

Where is Aptorum Group headquartered?

Aptorum Group is headquartered in London, United Kingdom.

When was Aptorum Group founded?

Aptorum Group was founded in 2017.

Which sector is Aptorum Group in?

Aptorum Group operates in Life Sciences Technology.

Who are Aptorum Group's competitors?

Companies similar to Aptorum Group include Cyclic Diagnostics, Blue Tractor Software, and MultiplAI Health.